Press Release Details
Fairfax Financial Holdings Limited: First Quarter Financial Results
(Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are prepared using the recognition and measurement requirements of International Financial Reporting Standards except as otherwise noted, and are unaudited.)
“Our insurance companies continued to have excellent underwriting performance in the first quarter of 2017 with a consolidated combined ratio of 94.6%. All of our insurance companies again had combined ratios less than 100%, with Zenith National at 80.2%, OdysseyRe at 90.4% and Fairfax Asia at 93.6%, and our operating income was strong at
The table below shows the sources of the company’s net earnings, set out in a format which the company has consistently used as it believes it assists in understanding Fairfax:
Quarter ended March 31, | ||||||
2017 | 2016 | |||||
Gross premiums written | 2,609.2 | 2,344.0 | ||||
Net premiums written | 2,275.0 | 2,030.3 | ||||
Underwriting profit | 107.2 | 121.7 | ||||
Interest and dividends – insurance and reinsurance | 101.5 | 125.0 | ||||
Operating income | 208.7 | 246.7 | ||||
Run-off (excluding net gains (losses) on investments) | (39.8 | ) | (15.0 | ) | ||
Non-insurance operations | (1.0 | ) | 12.3 | |||
Corporate overhead, interest expense and other | (49.3 | ) | (80.3 | ) | ||
Net losses on investments | (18.4 | ) | (159.6 | ) | ||
Pre-tax income | 100.2 | 4.1 | ||||
Income taxes and non-controlling interests | (17.6 | ) | (55.1 | ) | ||
Net earnings (loss) attributable to shareholders of Fairfax | 82.6 | (51.0 | ) |
Highlights in the first quarter of 2017 (with comparisons to the first quarter of 2016 except as otherwise noted) included the following:
- The combined ratio of the insurance and reinsurance operations was 94.6% on a consolidated basis, producing an underwriting profit of
$107.2 million , compared to a combined ratio and underwriting profit of 93.1% and$121.7 million respectively in 2016. - Net premiums written by the insurance and reinsurance operations increased by 12.0% to
$2,272.7 million (6.8% excluding the acquisitions ofBryte Insurance ,AMAG and Fairfirst Insurance completed during 2016). - The insurance and reinsurance operations produced operating income (excluding investment results) of
$208.7 million , compared to$246.7 million in 2016, reflecting decreased underwriting profit and lower interest income. - Interest and dividend income of
$128.1 million decreased from$152.8 million in 2016, primarily reflecting lower interest income earned as a result of the extensive sales of U.S. treasury and municipal bonds late in 2016 and in the first quarter of 2017, partially offset by lower total return swap expense. Interest income as reported is unadjusted for the positive tax effect of the company’s significant holdings of tax-advantaged debt securities (holdings of$2,833.7 million atMarch 31, 2017 and$3,263.9 million atDecember 31, 2016 ). - As at
March 31, 2017 , subsidiary cash and short term investments accounted for 40.4% of the company’s portfolio investments. - Net investment losses of
$18.4 million in 2017 (net investment losses of$159.6 million in 2016) consisted of the following:
First quarter of 2017 | ||||||||||
($ millions) | ||||||||||
Realized gains (losses) |
Unrealized gains (losses) |
Net gains (losses) |
||||||||
Net gains (losses) on: | ||||||||||
Long equity exposures | 76.1 | 146.0 | 222.1 | |||||||
Short equity exposures | (102.3 | ) | (80.8 | ) | (183.1 | ) | ||||
Net equity exposures | (26.2 | ) | 65.2 | 39.0 | ||||||
Bonds | 326.4 | (342.5 | ) | (16.1 | ) | |||||
CPI-linked derivatives | – | (15.3 | ) | (15.3 | ) | |||||
Other | (70.7 | ) | 44.7 | (26.0 | ) | |||||
229.5 | (247.9 | ) | (18.4 | ) |
- On
January 13, 2017 , the company purchased 12,340,500 subordinate voting shares ofFairfax India for$145.0 million ($11.75 per share) in a private placement. Through that private placement and a contemporaneous bought deal public offering,Fairfax India raised proceeds of$493.5 million net of commissions and expenses. - On
February 17, 2017 , the company purchased 30,000,000 multiple voting shares of newly incorporatedFairfax Africa in a private placement, and 2,500,000 subordinate voting shares ofFairfax Africa as part of that corporation’s IPO, for total consideration of$325 million ($10.00 per share). Through private placements and the IPO,Fairfax Africa raised gross proceeds of$506.2 million (net proceeds of$493.3 million after issuance costs and expenses). The company’s multiple voting and subordinate voting shares represented 98.8% of the voting rights and 64.2% of the equity interest inFairfax Africa at the close of the private placements and the IPO.Fairfax Africa was established, with the support of Fairfax, to invest in public and private equity and debt instruments of African businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on,Africa . - On
March 15, 2017 , the company closed its previously announced tender offers to purchase a targeted aggregate principal amount of up toCdn$250 million of certain of its outstanding senior notes. Pursuant to those tender offers, the company purchased principal amounts ofCdn$11.6 million ,Cdn$7.7 million andCdn$4.4 million of its notes due in 2019, 2020 and 2021 for cash consideration ofCdn$13.1 million ,Cdn$8.8 million andCdn$5.0 million respectively. - On
March 10, 2017 , Fairfax exercised its option to increase the cash consideration component of its offer to Allied World shareholders by$18.00 (out of a possible increase of$30.00 ) per ordinary share. As a result, the$54.00 per ordinary share consideration under the offer will consist of$23.00 cash per ordinary share payable by Fairfax, a$5.00 per ordinary share special cash dividend payable by Allied World and$26.00 per ordinary share payable in Fairfax stock. - The company held
$958.8 million of cash, short term investments and marketable securities at the holding company level ($943.9 million net of short sale and derivative obligations) atMarch 31, 2017 , compared to$1,371.6 million ($1,329.4 million net of short sale and derivative obligations) atDecember 31, 2016 . - The company’s total debt to total capital ratio decreased from 28.7% at
December 31, 2016 to 27.7% atMarch 31, 2017 , primarily reflecting the repayment ofFairfax India’s term loan. - At
March 31, 2017 , common shareholders’ equity was$8,326.5 million , or$361.02 per basic share, compared to$8,484.6 million , or$367.40 per basic share, atDecember 31, 2016 .
There were 23.1 million and 22.5 million weighted average shares outstanding during the first quarters of 2017 and 2016 respectively. At
Unaudited consolidated balance sheet, earnings and comprehensive income information, along with segmented premium and combined ratio information, follow and form part of this news release. Fairfax’s detailed first quarter report can be accessed at its website www.fairfax.ca.
As previously announced, Fairfax will hold a conference call to discuss its first quarter 2017 results at
Certain statements contained herein may constitute forward-looking statements and are made pursuant to the “safe harbour” provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Fairfax to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to: a reduction in net earnings if our loss reserves are insufficient; underwriting losses on the risks we insure that are higher or lower than expected; the occurrence of catastrophic events with a frequency or severity exceeding our estimates; changes in market variables, including interest rates, foreign exchange rates, equity prices and credit spreads, which could negatively affect our investment portfolio; the cycles of the insurance market and general economic conditions, which can substantially influence our and our competitors’ premium rates and capacity to write new business; insufficient reserves for asbestos, environmental and other latent claims; exposure to credit risk in the event our reinsurers fail to make payments to us under our reinsurance arrangements; exposure to credit risk in the event our insureds, insurance producers or reinsurance intermediaries fail to remit premiums that are owed to us or failure by our insureds to reimburse us for deductibles that are paid by us on their behalf; our inability to maintain our long term debt ratings, the inability of our subsidiaries to maintain financial or claims paying ability ratings and the impact of a downgrade of such ratings on derivative transactions that we or our subsidiaries have entered into; risks associated with implementing our business strategies; the timing of claims payments being sooner or the receipt of reinsurance recoverables being later than anticipated by us; risks associated with our use of derivative instruments; the failure of our hedging methods to achieve their desired risk management objective; a decrease in the level of demand for insurance or reinsurance products, or increased competition in the insurance industry; the impact of emerging claim and coverage issues or the failure of any of the loss limitation methods we employ; our inability to access cash of our subsidiaries; our inability to obtain required levels of capital on favourable terms, if at all; the loss of key employees; our inability to obtain reinsurance coverage in sufficient amounts, at reasonable prices or on terms that adequately protect us; the passage of legislation subjecting our businesses to additional supervision or regulation, including additional tax regulation, in
CONSOLIDATED BALANCE SHEETS
as at
(unaudited – US$ millions)
March 31, 2017 | December 31, 2016 | |||
Assets | ||||
Holding company cash and investments (including assets pledged for short sale and derivative obligations – $59.1; December 31, 2016 – $94.4) | 958.8 | 1,371.6 | ||
Insurance contract receivables | 2,994.9 | 2,917.5 | ||
Portfolio investments | ||||
Subsidiary cash and short term investments | 10,862.5 | 9,938.0 | ||
Bonds (cost $7,171.8; December 31, 2016 – $8,699.1) | 7,469.9 | 9,323.2 | ||
Preferred stocks (cost $122.0; December 31, 2016 – $111.2) | 82.8 | 69.6 | ||
Common stocks (cost $4,849.7; December 31, 2016 – $4,824.0) | 4,260.8 | 4,158.8 | ||
Investments in associates (fair value $3,372.2; December 31, 2016 – $2,955.4) | 2,685.1 | 2,393.0 | ||
Derivatives and other invested assets (cost $572.2; December 31, 2016 – $546.2) | 159.9 | 179.7 | ||
Assets pledged for short sale and derivative obligations (cost $230.9; December 31, 2016 – $223.9) | 231.0 | 228.5 | ||
Fairfax India and Fairfax Africa cash and portfolio investments | 1,806.0 | 1,002.6 | ||
27,558.0 | 27,293.4 | |||
Deferred premium acquisition costs | 720.8 | 693.1 | ||
Recoverable from reinsurers (including recoverables on paid losses – $400.9; December 31, 2016 – $290.9) | 4,039.3 | 4,010.3 | ||
Deferred income taxes | 772.8 | 732.6 | ||
Goodwill and intangible assets | 3,979.9 | 3,847.5 | ||
Other assets | 2,767.9 | 2,518.4 | ||
Total assets | 43,792.4 | 43,384.4 | ||
Liabilities | ||||
Accounts payable and accrued liabilities | 2,962.5 | 2,888.6 | ||
Income taxes payable | 52.2 | 35.4 | ||
Short sale and derivative obligations (including at the holding company – $14.9; December 31, 2016 – $42.2) | 122.2 | 234.3 | ||
Funds withheld payable to reinsurers | 405.4 | 416.2 | ||
Insurance contract liabilities | 23,335.6 | 23,222.2 | ||
Borrowings – holding company and insurance and reinsurance companies | 3,902.3 | 3,908.0 | ||
Borrowings – non-insurance companies | 776.8 | 859.6 | ||
Total liabilities | 31,557.0 | 31,564.3 | ||
Equity | ||||
Common shareholders’ equity | 8,326.5 | 8,484.6 | ||
Preferred stock | 1,335.5 | 1,335.5 | ||
Shareholders’ equity attributable to shareholders of Fairfax | 9,662.0 | 9,820.1 | ||
Non-controlling interests | 2,573.4 | 2,000.0 | ||
Total equity | 12,235.4 | 11,820.1 | ||
43,792.4 | 43,384.4 |
CONSOLIDATED STATEMENTS OF EARNINGS
for the three months ended
(unaudited – US$ millions except per share amounts)
First quarter | |||||||
2017 | 2016 | ||||||
Revenue | |||||||
Gross premiums written | 2,609.2 | 2,344.0 | |||||
Net premiums written | 2,275.0 | 2,030.3 | |||||
Gross premiums earned | 2,322.5 | 2,074.6 | |||||
Premiums ceded to reinsurers | (337.6 | ) | (298.2 | ) | |||
Net premiums earned | 1,984.9 | 1,776.4 | |||||
Interest and dividends | 128.1 | 152.8 | |||||
Share of profit of associates | 27.1 | 9.9 | |||||
Net losses on investments | (18.4 | ) | (159.6 | ) | |||
Other revenue | 615.9 | 407.0 | |||||
2,737.6 | 2,186.5 | ||||||
Expenses | |||||||
Losses on claims, gross | 1,397.7 | 1,224.6 | |||||
Losses on claims ceded to reinsurers | (232.4 | ) | (205.8 | ) | |||
Losses on claims, net | 1,165.3 | 1,018.8 | |||||
Operating expenses | 427.4 | 388.4 | |||||
Commissions, net | 390.8 | 318.0 | |||||
Interest expense | 70.6 | 55.2 | |||||
Other expenses | 583.3 | 402.0 | |||||
2,637.4 | 2,182.4 | ||||||
Earnings before income taxes | 100.2 | 4.1 | |||||
Provision for income taxes | 24.9 | 20.8 | |||||
Net earnings (loss) | 75.3 | (16.7 | ) | ||||
Attributable to: | |||||||
Shareholders of Fairfax | 82.6 | (51.0 | ) | ||||
Non-controlling interests | (7.3 | ) | 34.3 | ||||
75.3 | (16.7 | ) | |||||
Net earnings (loss) per share | $3.11 | $(2.76 | ) | ||||
Net earnings (loss) per diluted share | $3.03 | $(2.76 | ) | ||||
Cash dividends paid per share | $10.00 | $10.00 | |||||
Shares outstanding (000) (weighted average) | 23,079 | 22,530 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
for the three months ended
(unaudited – US$ millions)
First quarter | ||||||||
2017 | 2016 | |||||||
Net earnings (loss) | 75.3 | (16.7 | ) | |||||
Other comprehensive income, net of income taxes | ||||||||
Items that may be subsequently reclassified to net earnings | ||||||||
Net unrealized foreign currency translation gains on foreign operations | 126.6 | 176.1 | ||||||
Losses on hedge of net investment in Canadian subsidiaries | (8.0 | ) | (81.2 | ) | ||||
Share of other comprehensive income of associates, excluding net gains on defined benefit plans | 3.3 | 4.0 | ||||||
121.9 | 98.9 | |||||||
Items that will not be subsequently reclassified to net earnings | ||||||||
Share of net gains on defined benefit plans of associates | 1.0 | 1.5 | ||||||
Other comprehensive income, net of income taxes | 122.9 | 100.4 | ||||||
Comprehensive income | 198.2 | 83.7 | ||||||
Attributable to: | ||||||||
Shareholders of Fairfax | 144.0 | 21.4 | ||||||
Non-controlling interests | 54.2 | 62.3 | ||||||
198.2 | 83.7 |
SEGMENTED INFORMATION
(unaudited – US$ millions)
Net premiums written and net premiums earned by the insurance and reinsurance operations (excluding Runoff) in the first quarters ended
Net Premiums Written
2017 | 2016 | ||||
Northbridge | 213.9 | 181.0 | |||
OdysseyRe | 555.2 | 483.5 | |||
Crum & Forster | 451.1 | 440.8 | |||
Zenith National | 331.8 | 327.6 | |||
Brit | 394.4 | 405.3 | |||
Fairfax Asia | 100.1 | 65.0 | |||
Insurance and Reinsurance – Other | 226.2 | 126.9 | |||
Insurance and reinsurance operations | 2,272.7 | 2,030.1 |
Net Premiums Earned
2017 | 2016 | ||||
Northbridge | 235.8 | 209.2 | |||
OdysseyRe | 498.9 | 461.4 | |||
Crum & Forster | 445.3 | 422.3 | |||
Zenith National | 188.2 | 187.3 | |||
Brit | 341.4 | 342.6 | |||
Fairfax Asia | 76.3 | 50.4 | |||
Insurance and Reinsurance – Other | 195.2 | 103.0 | |||
Insurance and reinsurance operations | 1,981.1 | 1,776.2 |
Combined ratios of the insurance and reinsurance operations (excluding Runoff) in the first quarters ended
2017 | 2016 | ||||
Northbridge | 98.9% | 98.6% | |||
OdysseyRe | 90.4% | 90.3% | |||
Crum & Forster | 99.5% | 97.6% | |||
Zenith National | 80.2% | 83.4% | |||
Brit | 96.8% | 96.0% | |||
Fairfax Asia | 93.6% | 76.5% | |||
Insurance and Reinsurance – Other | 99.5% | 92.7% | |||
Insurance and reinsurance operations | 94.6% | 93.1% |
(416) 367-4941